108 related articles for article (PubMed ID: 8912130)
21. [Prophylactic antibiotic therapy with amoxicillin-clavulanic acid in oropharyngeal surgery].
Navarro M; Scola E; Scola B; Ortiz P; Martínez T; Vega MF
Acta Otorrinolaringol Esp; 1995; 46(1):41-4. PubMed ID: 7734163
[TBL] [Abstract][Full Text] [Related]
22. Management of common bile duct stones: selective endoscopic retrograde cholangiography and endoscopic sphincterotomy: short- and long-term results.
Schreurs WH; Juttmann JR; Stuifbergen WN; Oostvogel HJ; van Vroonhoven TJ
Surg Endosc; 2002 Jul; 16(7):1068-72. PubMed ID: 11984690
[TBL] [Abstract][Full Text] [Related]
23. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
[TBL] [Abstract][Full Text] [Related]
24. Guidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation.
Artifon EL; Sakai P; Cunha JE; Halwan B; Ishioka S; Kumar A
Am J Gastroenterol; 2007 Oct; 102(10):2147-53. PubMed ID: 17581267
[TBL] [Abstract][Full Text] [Related]
25. [Clinical experience with Timentin].
Vacek V; Benes J; Kabelková M
Cas Lek Cesk; 1997 Dec; 136(24):764-7. PubMed ID: 9511261
[TBL] [Abstract][Full Text] [Related]
26. Outcome and early complications of ERCP: a prospective single center study.
Suissa A; Yassin K; Lavy A; Lachter J; Chermech I; Karban A; Tamir A; Eliakim R
Hepatogastroenterology; 2005; 52(62):352-5. PubMed ID: 15816433
[TBL] [Abstract][Full Text] [Related]
27. [Antibiotic prophylaxis for high risk patients undergoing cholecystectomy].
Zsirka KA; Pulay I; Arr M; Williams C; Flautner L
Magy Seb; 2000 Jun; 53(3):104-8. PubMed ID: 11299497
[TBL] [Abstract][Full Text] [Related]
28. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.
Deenadayalu VP; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Temkit M; Lehman GA; Sherman S
J Clin Gastroenterol; 2008; 42(10):1103-9. PubMed ID: 18936645
[TBL] [Abstract][Full Text] [Related]
29. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
Lee KT; Lee DH; Yoo BM
Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
[TBL] [Abstract][Full Text] [Related]
30. Silent myocardial ischaemia during endoscopic retrograde cholangiopancreatography.
Johnston SD; McKenna A; Tham TC
Endoscopy; 2003 Dec; 35(12):1039-42. PubMed ID: 14648418
[TBL] [Abstract][Full Text] [Related]
31. [Selection criteria for endoscopic cholangiopancreatography before laparoscopic cholecystectomy].
Güitrón-Cantú A; Adalid-Martínez R; Gutiérrez-Bermúdez JA
Rev Gastroenterol Mex; 2002; 67(3):166-70. PubMed ID: 12653053
[TBL] [Abstract][Full Text] [Related]
32. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study.
Masci E; Toti G; Mariani A; Curioni S; Lomazzi A; Dinelli M; Minoli G; Crosta C; Comin U; Fertitta A; Prada A; Passoni GR; Testoni PA
Am J Gastroenterol; 2001 Feb; 96(2):417-23. PubMed ID: 11232684
[TBL] [Abstract][Full Text] [Related]
33. Risk factors in vascular surgical sepsis.
Earnshaw JJ; Slack RC; Hopkinson BR; Makin GS
Ann R Coll Surg Engl; 1988 May; 70(3):139-43. PubMed ID: 3408172
[TBL] [Abstract][Full Text] [Related]
34. [Retrograde endoscopic cholangiopancreatography. Incidence of bacteremia].
Marsicano LJ; Serrano N; Urrestarazu MI; Poleo JR
G E N; 1990; 44(1):28-34. PubMed ID: 2152252
[TBL] [Abstract][Full Text] [Related]
35. Duration of antimicrobial prophylaxis in vascular surgery.
Hall JC; Christiansen KJ; Goodman M; Lawrence-Brown M; Prendergast FJ; Rosenberg P; Mills B; Hall JL
Am J Surg; 1998 Feb; 175(2):87-90. PubMed ID: 9515521
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients.
Davis AJ; Kolios G; Alveyn CG; Robertson DA
Aliment Pharmacol Ther; 1998 Mar; 12(3):207-11. PubMed ID: 9570254
[TBL] [Abstract][Full Text] [Related]
37. Preventing post-ERCP pancreatitis: where are we?
Testoni PA
JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
[TBL] [Abstract][Full Text] [Related]
38. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial.
Beauchant M; Ingrand P; Favriel JM; Dupuychaffray JP; Capony P; Moindrot H; Barthet M; Escourrou J; Plane C; Barrioz T; Lacoste L; Ingrand I
Endoscopy; 2008 Aug; 40(8):631-6. PubMed ID: 18680075
[TBL] [Abstract][Full Text] [Related]
39. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
40. Is the supine position as safe and effective as the prone position for endoscopic retrograde cholangiopancreatography? A prospective randomized study.
Terruzzi V; Radaelli F; Meucci G; Minoli G
Endoscopy; 2005 Dec; 37(12):1211-4. PubMed ID: 16329019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
